Controversies in the design of phase II clinical trials.
Seymour
Lesley
L
Investigational New Drug Program, Audit and Monitoring Group of the NCIC Clinical Trials Group, Kingston, Ontario K7L3N6, Canada.
D017322:Clinical Trials, Phase II as Topic; D018572:Disease-Free Survival; D006801:Humans; D012107:Research Design; D016896:Treatment Outcome